Color Health, Inc. (founded as Color Genomics) is an American healthcare company focused on cancer care delivery. The company operates a Virtual Cancer Clinic that provides services in cancer prevention, detection, screening, diagnosis, and survivorship care.

Color was co-founded in 2015 by Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki, who serves as the company's CEO, in Burlingame, California.

In November 2021, the company raised $100 million in a Series E financing round led by General Catalyst.

In 2023, Color refocused its efforts from population genomics and COVID-19 testing to cancer care delivery, introducing its Virtual Cancer Clinic, a wholly-owned, vertically integrated cancer care platform that offers early detection, oncology based care, and survivorship support as an employer-offered health care benefit.

In 2023, Color Health launched its Virtual Cancer Clinic to provide cancer risk assessment, early detection, treatment coordination, and survivorship support. Care is delivered in accordance with established clinical guidelines by oncology-trained clinicians, primary care physicians, and genetic counselors licensed in all 50 U.S. states.

According to the company, first-year participation typically ranges from 20 to 30 percent of eligible individuals, with reported increases in screening adherence of up to 77 percent and shorter timelines from screening to diagnosis by up to 55 percent.

External reporting has noted that Color piloted the use of artificial intelligence tools to generate cancer screening and diagnostic plans, with the goal of reducing missed workups and creating standardized recommendations.

The Virtual Cancer Clinic also includes behavioral health support programs, a national imaging network, and care advocacy services.